卡非佐米相关血栓性微血管病最初采用治疗性血浆置换进行治疗。
Carfilzomib associated thrombotic microangiopathy initially treated with therapeutic plasma exchange.
作者信息
Sullivan Matthew R, Danilov Alexey V, Lansigan Frederick, Dunbar Nancy M
机构信息
Department of Medicine, Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire.
Department of Hematology/Oncology, Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire.
出版信息
J Clin Apher. 2015 Oct;30(5):308-10. doi: 10.1002/jca.21371. Epub 2014 Nov 21.
PMID:25413611
Abstract
Drug associated thrombotic microangiopathy (TMA) is a rare event causing thrombocytopenia, microangiopathic anemia, renal failure, and neurologic abnormalities. Here, we present a case of TMA that occurred during the first cycle of treatment with carfilzomib for relapsed multiple myeloma.
摘要
药物相关血栓性微血管病（TMA）是一种罕见的病症，可导致血小板减少、微血管病性贫血、肾衰竭和神经功能异常。在此，我们报告一例在使用卡非佐米治疗复发多发性骨髓瘤的首个疗程中发生的TMA病例。
Zotero 插件